If a partner enter in a deal, the company will be repriced immediately.
Any shareholder that will sell under a certain target that considers the repricing, will loose an opportunity. Biotechs are subject to volatility, but once a shareholder is out, he/she will find hard to enter again.
FTT Price at posting:
3.9¢ Sentiment: Buy Disclosure: Held